Literature DB >> 10748206

Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alpha.

G H Peters1, L F Iversen, S Branner, H S Andersen, S B Mortensen, O H Olsen, K B Moller, N P Moller.   

Abstract

The aim of this study was to define the structural elements that determine the differences in substrate recognition capacity of two protein-tyrosine phosphatases (PTPs), PTP1B and PTPalpha, both suggested to be negative regulators of insulin signaling. Since the Ac-DADE(pY)L-NH(2) peptide is well recognized by PTP1B, but less efficiently by PTPalpha, it was chosen as a tool for these analyses. Calpha regiovariation analyses and primary sequence alignments indicate that residues 47, 48, 258, and 259 (PTP1B numbering) define a selectivity-determining region. By analyzing a set of DADE(pY)L analogs with a series of PTP mutants in which these four residues were exchanged between PTP1B and PTPalpha, either in combination or alone, we here demonstrate that the key selectivity-determining residue is 259. In PTPalpha, this residue is a glutamine causing steric hindrance and in PTP1B a glycine allowing broad substrate recognition. Significantly, replacing Gln(259) with a glycine almost turns PTPalpha into a PTP1B-like enzyme. By using a novel set of PTP inhibitors and x-ray crystallography, we further provide evidence that Gln(259) in PTPalpha plays a dual role leading to restricted substrate recognition (directly via steric hindrance) and reduced catalytic activity (indirectly via Gln(262)). Both effects may indicate that PTPalpha regulates highly selective signal transduction processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748206     DOI: 10.1074/jbc.M910273199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop.

Authors:  F Rodrigues-Lima; C Deloménie; G H Goodfellow; D M Grant; J M Dupret
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

3.  The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.

Authors:  Jeyanthy Eswaran; Judit E Debreczeni; Emma Longman; Alastair J Barr; Stefan Knapp
Journal:  Protein Sci       Date:  2006-05-02       Impact factor: 6.725

4.  Regulation of Connexin32 by ephrin receptors and T-cell protein-tyrosine phosphatase.

Authors:  Andrew J Trease; Hanjun Li; Gaelle Spagnol; Li Zheng; Kelly L Stauch; Paul L Sorgen
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

Review 5.  The Gewald multicomponent reaction.

Authors:  Yijun Huang; Alexander Dömling
Journal:  Mol Divers       Date:  2010-02-27       Impact factor: 2.943

6.  TC-PTP directly interacts with connexin43 to regulate gap junction intercellular communication.

Authors:  Hanjun Li; Gaelle Spagnol; Naava Naslavsky; Steve Caplan; Paul L Sorgen
Journal:  J Cell Sci       Date:  2014-05-20       Impact factor: 5.285

7.  Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.

Authors:  Rongxing Liu; Yujie Sun; Jérémy Berthelet; Linh-Chi Bui; Ximing Xu; Mireille Viguier; Jean-Marie Dupret; Frédérique Deshayes; Fernando Rodrigues Lima
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

8.  Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis.

Authors:  Anja K Pedersen; Xiao-Ling Guo; Karin B Møller; Günther H Peters; Henrik S Andersen; Jette S Kastrup; Steen B Mortensen; Lars F Iversen; Zhong-Yin Zhang; Niels Peter H Møller
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 9.  Protein tyrosine phosphatases: structure, function, and implication in human disease.

Authors:  Lutz Tautz; David A Critton; Stefan Grotegut
Journal:  Methods Mol Biol       Date:  2013

10.  A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).

Authors:  Paul G Drake; Günther H Peters; Henrik Sune Andersen; Wiljan Hendriks; Niels Peter H Møller
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.